News, Analysis & Insights on Nutrition, Supplements, and Health
For centuries, coca leaf has played an important cultural and traditional role in the Andes. But outside South America, the plant is far more likely to be associated with one thing: cocaine. So what happens when we separate the coca leaf from the drug...
FDA wants companies to notify the agency when they determine food ingredients are Generally Recognized As Safe. But with hundreds of potential notifications and fewer staff, questions remain over whether FDA has the resources to review them
Synthetic spokespeople may be new, but industry experts say brands remain responsible for substantiated claims, truthful endorsements and transparent marketing.
The dietary supplement industry is facing a new layer of supply-chain uncertainty as geopolitical tensions, tariffs, energy prices and freight disruptions ripple through the global ingredient market.
Dr. Heidi Overton was nominated by President Donald Trump to lead the Food and Drug Administration, the White House announced Wednesday.
Quten Research Institute is facing a proposed class action alleging that its Qunol Ultra Omega-3 Fish Oil contains less omega-3 than the 1,000 mg advertised on the product label.
Connected wellness products offer supplement companies opportunities to reach beyond traditional categories, but that move may also expose them to new safety requirements and closer regulatory scrutiny.
Venable’s Todd Harrison questions FDA’s authority to mandate Generally Recognized As Safe (GRAS) notifications and says the proposal could create significant uncertainty for ingredient suppliers and functional food and beverage companies.
The dispute highlights how competing measures of market leadership can determine which supplement brands are able to claim the top spot.
Canomiks’ evidence-based platform aims to help consumers distinguish product-specific science from marketing claims while encouraging greater transparency across the dietary supplement industry.
Ryse Up Sports Nutrition is facing a proposed class action alleging its Ryse Clear Protein Drinks contain between 6% and 11% less protein than the 22 g declared on the label.
The proposed legislation would establish a federal regulatory framework for hemp-derived cannabinoid products, which industry stakeholders say could provide long-sought regulatory certainty for manufacturers and create a clearer pathway for nutrition and...
The United States Patent and Trademark Office has issued The Akkermansia Company (TAC) with a new patent, granting the company the exclusive right to market Akkermansia for metabolic disorders.
In response, TruHeight stated it has already implemented broader compliance measures, including external regulatory oversight and updated review policies.
Catch up with our weekly round-up of key news from across the Nutraverse.
From regulation and women’s health to healthy aging and commercialization, this year’s conference brought together the people and ideas shaping the next chapter of microbiome innovation.
The companion animal supplement industry in North America operates on intricate frameworks that are changing quickly as regulatory environments shift.
The U.S. International Trade Commission (USITC) has initiated an investigation into alleged gray-market imports of Monster Energy Company products following a complaint that certain imported energy drinks and their labeling infringe several of the...
The case highlights how consumer perception can lead to false advertising allegations, even when labels comply with FDA requirements.
Patented prebiotic fiber blend Myota has raised $4.5 million in a Series A round led by venture capital firm PeakBridge to expand its clinically validated prebiotic fibre business.
After 34 years of industry leadership and advocacy, the United Natural Products Alliance (UNPA) will conclude operations at the end of 2026, following the retirement of its founder and president, Loren Israelsen.
Consumers are increasingly taking supplements and more than two decades of consumption may explain how trends have evolved.
The Natural Products Association (NPA) met with representatives of the Texas attorney general’s office last week to discuss the state’s industry-wide investigation into protein powder manufacturers.
Function, a health platform that provides lab testing, imaging and personalized health insights, has acquired SuppCo, a supplement intelligence platform focused on helping consumers evaluate supplement quality and trustworthiness.
A U.S. Food and Drug Administration warning letter issued earlier this year is continuing to spur conversation about the appropriate use of AI to comply with the agency’s regulations.
Guest article
On June 10, executives from across the dietary supplement and functional food industry will gather in Washington, D.C., for CRN’s annual Day on the Hill. We will spend the day meeting with Members of Congress and their staff to discuss policies that...
Catch up with our weekly round-up of key news from across the Nutraverse.
Described by one attendee as “an event with wall-to-wall speakers who delivered insightful, topical, useable information”, the Nutra Healthspan Summit is returning to London for its 2nd edition with more high-level content and networking opportunities.
Probiota Americas is less than two weeks away with must-see speakers on Day 1 including Nick Gibson (Nielsen IQ), Peter McMath (WPIC), Dr. Stan Kubow (McGill University), Dr Martha Cline (Nestlé Purina Petcare), Dr. Anna Lindell (Cambiotics), and more!
Senators Kevin Cramer (R-ND) and John Curtis (R-UT) have introduced the Dietary Supplements Access Act to amend the Internal Revenue Code to recognize dietary supplements as qualified medical expenses eligible for reimbursement through Health Savings...
The FDA investigation, which closed April 1, tied recalled moringa supplements to more than 100 illnesses, drawing renewed industry attention to testing, traceability and supplier verification practices.
Supplement gummy production is known for being challenging as companies must consider everything from sugar content to foreign material exposure.
News in brief
The Karnataka High Court in Bangalore has temporarily stayed the Indian government’s restriction on the use of ashwagandha leaves issued last month after industry stakeholders challenged the rationale behind the blanket ban.